Arthritis is an inflammatory disorder that occurs in joints and surrounding tissues. There are six types of arthritis namely osteoarthritis, autoimmune arthritis, psoriatic arthritis, juvenile arthritis, gout arthritis, and infectious arthritis. Symptoms of arthritis can include pain, swelling, redness, stiffness and decrease in movement. Some of the risk factors associated with arthritis are aging, obesity, joint injury, and family history. Certain laboratory tests such as blood test, and urine test, and imaging techniques such as computed tomography, magnetic resonance imaging, X-rays, and ultrasound, are being used to diagnose arthritis. EMD Serono, Inc. is in the process of developing evobrutinib as an agammaglobulinaemia tyrosine kinase inhibitor for the treatment of arthritis. Sanofi SA is in the process of developing as an interleukin 6 receptor antagonist for the treatment of arthritis. Some of the companies having the pipeline of arthritis include Bristol-Myers Squibb Company, Translational Biosciences, Inc., and others.
The report provides a comprehensive understanding of the pipeline activities covering all drug candidates under various stages of development, with the detailed analysis of pipeline and clinical trials. Pipeline analysis of drugs by phases includes product description and development activities including information about clinical results, designations, collaborations, licensing, grants, technology, and others.